TABLE 11.
Outcome | θ = 0° | 0° < θ ≤ 30° | 30° < θ ≤ 60° | 60° < θ ≤ 90° | 90° < θ ≤ 180° |
---|---|---|---|---|---|
Female age, mean years ± SD a | 34.7 ± 3.8 | 35.4 ± 3.7 | 33.5 ± 3.9 | 33.7 ± 4.4 | 36.0 ± 4.1 |
n (%) | n (%) | n (%) | n (%) | n (%) | |
ICSI b | |||||
MII oocytes c | 154 | 61 | 42 | 20 | 7 |
2PN2PB oocytes | 106 (68.8) | 47 (77.0) | 33 (78.6) | 16 (80.0) | 5 (71.4) |
1PN oocytes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Multi‐PN oocytes | 4 (2.6) | 3 (4.9) | 1 (2.4) | 2 (10.0) | 0 (0.0) |
No‐PN oocytes | 10 (6.5) | 3 (4.9) | 3 (7.1) | 1 (5.0) | 0 (0.0) |
Unfertilized oocytes | 26 (16.9) | 4 (6.6) | 4 (9.5) | 1 (5.0) | 1 (14.3) |
Broken oocytes | 8 (5.2) | 4 (6.6) | 1 (2.4) | 0 (0.0) | 1 (14.3) |
Embryo development | |||||
Cultured 2PN2PB d | 90 | 42 | 27 | 15 | 5 |
Blastocysts | 65 (72.2) | 30 (71.4) | 14 (51.9) | 10 (66.7) | 5 (100.0) |
Pregnancy, live birth, and miscarriage | |||||
Blastocyst transfer cycles | 31 | 10 | 7 | 3 | 3 |
hCG‐positive | 12 (38.7) | 6 (60.0) | 2 (28.6) | 1 (33.3) | 1 (33.3) |
GS‐positive | 7 (22.6) | 5 (50.0) | 2 (28.6) | 1 (33.3) | 1 (33.3) |
FHM‐positive | 6 (19.4) | 5 (50.0) | 1 (14.3) | 1 (33.3) | 0 (0.0) |
LB/OP | 5 (16.1) | 3 (30.0) | 1 (14.3) | 1 (33.3) | – |
Miscarriage e | 2 (28.6) | 2 (40.0) | 1 (50.0) | 0 (0.0) | 1 (100.0) |
Note: Holm test used to determine significance.
Abbreviations: FHM, fetal heart movement; GS, gestational sac; hCG, human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection; LB/OP, live birth or ongoing pregnancy; MII, metaphase II; PB, polar body; PN, pronuclei.
Steel–Dwass test.
ICSI cycles using frozen‐thawed spermatozoa, spermatozoa retrieved by testicular sperm extraction, or oocytes that were artificially activated were excluded from the analysis.
Oocyte with spindle within ooplasm.
2PN2PB oocytes cultured until confirmation of blastocyst formation.
Rate of miscarriage = Patients with miscarriage (n)/GS‐positive patients (n) × 100.